Sudha Warrier
Sudha Warrier
Manipal School of Regenerative Medicine
Verified email at
Cited by
Cited by
Occurrence of vertebrate steroids, estradiol 17β and progesterone in the reproducing females of the mud crab Scylla serrata
SR Warrier, R Tirumalai, T Subramoniam
Comparative Biochemistry and Physiology Part A: Molecular & Integrative …, 2001
Secreted frizzled related proteins: Implications in cancers
R Surana, S Sikka, W Cai, EM Shin, SR Warrier, HJG Tan, F Arfuso, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (1), 53-65, 2014
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
MK Shanmugam, S Warrier, AP Kumar, G Sethi, F Arfuso
Current vascular pharmacology 15 (6), 503-519, 2017
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial …
S Warrier, G Bhuvanalakshmi, F Arfuso, G Rajan, M Millward, ...
Cancer gene therapy 21 (9), 381-388, 2014
Pro-apoptotic and anti-cancer properties of diosgenin: a comprehensive and critical review
G Sethi, MK Shanmugam, S Warrier, M Merarchi, F Arfuso, AP Kumar, ...
Nutrients 10 (5), 645, 2018
Receptor mediated yolk protein uptake in the crab Scylla serrata: crustacean vitellogenin receptor recognizes related mammalian serum lipoproteins
S Warrier, T Subramoniam
Molecular reproduction and development 61 (4), 536-548, 2002
Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells
S Warrier, SK Balu, AP Kumar, M Millward, A Dharmarajan
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 21 …, 2014
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties
F Arfuso, M Millward, A Dharmarajan, S Warrier
PloS one 10 (6), e0127517, 2015
Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt β-catenin signaling via the Wnt antagonist secreted frizzled …
G Bhuvanalakshmi, KS Rangappa, A Dharmarajan, G Sethi, AP Kumar, ...
Frontiers in pharmacology 8, 124, 2017
Role of novel histone modifications in cancer
MK Shanmugam, F Arfuso, S Arumugam, A Chinnathambi, B Jinsong, ...
Oncotarget 9 (13), 11414, 2018
Inherent propensity of amnion-derived mesenchymal stem cells towards endothelial lineage: vascularization from an avascular tissue
S Warrier, N Haridas, R Bhonde
Placenta 33 (10), 850-858, 2012
Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme
L Schiefer, M Visweswaran, V Perumal, F Arfuso, D Groth, P Newsholme, ...
Cancer gene therapy 21 (7), 297-303, 2014
Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays
S Warrier, P Pavanram, D Raina, M Arvind
Cell biology international 36 (12), 1137-1143, 2012
‘Lnc’‐ing Wnt in female reproductive cancers: therapeutic potential of long non‐coding RNAs in Wnt signalling
MS Ong, W Cai, Y Yuan, HC Leong, TZ Tan, A Mohammad, ML You, ...
British journal of pharmacology 174 (24), 4684-4700, 2017
The expanding roles of long non-coding RNAs in the regulation of cancer stem cells
Z Ma, YY Wang, HW Xin, L Wang, F Arfuso, A Dharmarajan, AP Kumar, ...
The international journal of biochemistry & cell biology 108, 17-20, 2019
Epigenetic reprogramming converts human Wharton’s jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators
G Bhuvanalakshmi, F Arfuso, AP Kumar, A Dharmarajan, S Warrier
Stem cell research & therapy 8 (1), 1-15, 2017
Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs
S Mandal, F Arfuso, G Sethi, A Dharmarajan, S Warrier
The international journal of biochemistry & cell biology 110, 59-69, 2019
Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells
M Visweswaran, F Arfuso, S Warrier, A Dharmarajan
Stem cells 38 (1), 6-14, 2020
A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells.
AD S R Warrier, N Haridas, S Balasubramanian, A Jalisatgi, R Bhonde
Cell Proliferation 46 (3), 283-90, 2013
Stemness, pluripotentiality, and Wnt antagonism: sFRP4, a Wnt antagonist mediates pluripotency and stemness in glioblastoma
G Bhuvanalakshmi, N Gamit, M Patil, F Arfuso, G Sethi, A Dharmarajan, ...
Cancers 11 (1), 25, 2019
The system can't perform the operation now. Try again later.
Articles 1–20